Utilizza questo identificativo per citare o creare un link a questo documento:
|Titolo:||N6-Cycloalkyl- and N6-Bicycloalkyl-C5′(C2′)-modiﬁed Adenosine Derivatives as High-Afﬁnity and Selective Agonists at the Human A(1) Adenosine Receptor with Antinociceptive Effects in Mice|
|Autori interni:||CAPPELLACCI, Loredana|
|Data di pubblicazione:||2009|
|Rivista:||JOURNAL OF MEDICINAL CHEMISTRY|
|Abstract:||To further investigate new potent and selective human A(1) adenosine receptor agonists, we have synthesized a series of 5'-chloro-5'-deoxy- and 5'-(2-fluorophenylthio)-5'-deoxy-N-6-cycloalkyl(bicycloalkyl)-substituted adenosine and 2'-C-methyladenosine derivatives. These compounds were evaluated for affinity and efficacy at human A,, A(2A), A(2B), and A(3) adenosine receptors. In the series of N-6-cyclopentyl- and N-6-(endo-norborn2-yl)adenosine derivatives, 5'-chloro-5'-deoxy-CPA (1) and 5'-chloro-5'-deoxy-(+/-)-ENBA (3) displayed the highest affinity in the subnanomolar range and relevant selectivity for hA(1) vs the other human receptor subtypes. The higher affinity and selectivity of 5'-chloro-5'-deoxyribonucleoside derivatives 1 and 3 for hA(1) AR vs hA(3) AR compared to that of the parent 5'-hydroxy compounds CPA and (+/-)-ENBA was rationalized by a molecular modeling analysis. 5'-Chloro-5'-deoxy-(+/-)-ENBA, evaluated for analgesic activity in the formalin test in mice, was found to inhibit the first or the second phases of the nocifensive response induced by intrapaw injection of formalism at doses ranging between 1 and 2 mg/kg i.p.|
|Appare nelle tipologie:||Articolo|
File in questo prodotto:
Non ci sono file associati a questo prodotto.
- PubMed Central loading...
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.